Dicyclomine
Unchecked
Dicyclomine
Bentyl
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Common uses
Irritable bowel syndrome (functional bowel disease)0, Visceral smooth muscle spasm0
Pharmacy
Starting dose
20 mg PO QID (start 10 mg and titrate); IM 20 mg q6h short-term
Preparations
10, 20 mg tablets/capsules; 10 mg/5 mL syrup; 10 mg/mL IM injection
US FDA Max
160 mg/d (rarely tolerated due to anticholinergic effects)
Pharmacology
Routes
Oral, IM (not for IV)
Onset
1-2 hours PO
Duration
4 hours
Half-life
~1.8 hours (initial); ~10 hours (terminal)[1]
Bioavailability
~67% (oral)[1]
Pregnancy
Generally avoided; not first-line.[citation needed]
Legal status
Rx-only in US
Purported mechanism
Dicyclomine non-selectively antagonizes muscarinic receptors on GI smooth muscle, reducing tone and motility; it also has direct local anesthetic-like effects on smooth muscle independent of muscarinic blockade.0 The non-selective antimuscarinic profile produces the characteristic systemic anticholinergic burden (dry mouth, blurred vision, constipation, urinary retention, confusion in elderly). On the AGS Beers list as potentially inappropriate in older adults[1].
References
[edit | edit source]- ↑ 1.0 1.1 1.2 FDA Prescribing Information, Bentyl (dicyclomine HCl), Allergan, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/007409s044,007783s045lbl.pdf